Last reviewed · How we verify

NCT04200742: STABAL

Standardized BAL Procedure for Critical Patients to Diagnose Pneumonia Pathogens

Status unknown Last updated 16 December 2019
What this trial tests

trial in Bronchoalveolar Lavage in 30 participants. Status unknown.

Timeline
16 September 2019
Primary endpoint
1 May 2020
1 June 2020

Quick facts

Lead sponsorWu Jianfeng
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date16 September 2019
Primary completion1 May 2020
Estimated completion1 June 2020
Sites1 location across China

Conditions studied

Sponsor

Wu Jianfeng

Who can join

Adults 18 to 90, any sex, with Bronchoalveolar Lavage or Pneumonia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In order to improve the accuracy of the diagnosis of pulmonary pathogens and reduce the adverse impact of excessive BAL volume on patients, this study intends to explore the most optimal lavage volume in the middle lobe and the lower lobe of critical patients as well as seeking for the best way to manage BALF samples by means of detecting alveolar proteins and bacterial composition in BALF samples. The hypothesis is that the optimal lavage volume in the middle lobe and the lower lobe might be different. And to sample BALF separately through sequential lavage might be a better way to improve the accuracy of the diagnosis of pneumonia pathogens.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Bronchoalveolar Lavage

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04200742.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing